Pretax income is the income that a company earns before paying income taxes. Alkermes's pretax income for the
three
months ended in Dec. 2023 was $182 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $422 Mil.
Alkermes's pretax margin was 48.28%.
During the past 13 years, Alkermes's highest Pretax Margin was 25.34%. The lowest was -35.65%. And the median was -10.45%.
Alkermes Pre-Tax Income Historical Data
The historical data trend for Alkermes's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Alkermes's Pre-Tax Income
For the Drug Manufacturers - Specialty & Generic subindustry, Alkermes's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alkermes's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alkermes's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Alkermes's Pre-Tax Income falls into.
Alkermes Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Alkermes's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $422 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alkermes (NAS:ALKS) Pre-Tax Income Explanation
Alkermes's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, Alkermes's highest Pretax Margin was 25.34%. The lowest was -35.65%. And the median was -10.45%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alkermes Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Alkermes's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALKS has been successfully added to your 